Integrated safety analysis of treatment-emergent eczematous reactions in patients with moderate-to-severe psoriasis treated with ixekizumab, etanercept and ustekinumab

P. M. Brunner; C. Conrad; R. Vender; S. Grond; C. Schuster; H. Patel; W. Xu; J. M. Carrascosa Carrillo

doi:10.1111/bjd.20527

Integrated safety analysis of treatment-emergent eczematous reactions in patients with moderate-to-severe psoriasis treated with ixekizumab, etanercept and ustekinumab

P. M. Brunner
, C. Conrad
, R. Vender
, S. Grond
, C. Schuster
, H. Patel
, W. Xu
, J. M. Carrascosa Carrillo

Research output: Contribution to journal › Letter › peer-review

9 Scopus citations

Original language	English
Pages (from-to)	865-867
Number of pages	3
Journal	British Journal of Dermatology
Volume	185
Issue number	4
DOIs	https://doi.org/10.1111/bjd.20527
State	Published - Oct 2021
Externally published	Yes

Access to Document

10.1111/bjd.20527

Cite this

Brunner, P. M., Conrad, C., Vender, R., Grond, S., Schuster, C., Patel, H., Xu, W., & Carrascosa Carrillo, J. M. (2021). Integrated safety analysis of treatment-emergent eczematous reactions in patients with moderate-to-severe psoriasis treated with ixekizumab, etanercept and ustekinumab. British Journal of Dermatology, 185(4), 865-867. https://doi.org/10.1111/bjd.20527

@article{3e9195f4a362428e8757a75401a49ae0,

title = "Integrated safety analysis of treatment-emergent eczematous reactions in patients with moderate-to-severe psoriasis treated with ixekizumab, etanercept and ustekinumab",

author = "Brunner, \{P. M.\} and C. Conrad and R. Vender and S. Grond and C. Schuster and H. Patel and W. Xu and \{Carrascosa Carrillo\}, \{J. M.\}",

note = "Funding Information: sources: Eli Lilly and Company.we would like to thank Chenyun Tan, PharmD, an employee of Eli Lilly and Company, for medical writing assistance.",

year = "2021",

month = oct,

doi = "10.1111/bjd.20527",

language = "English",

volume = "185",

pages = "865--867",

journal = "British Journal of Dermatology",

issn = "0007-0963",

publisher = "Oxford University Press",

number = "4",

}

Brunner, PM, Conrad, C, Vender, R, Grond, S, Schuster, C, Patel, H, Xu, W & Carrascosa Carrillo, JM 2021, 'Integrated safety analysis of treatment-emergent eczematous reactions in patients with moderate-to-severe psoriasis treated with ixekizumab, etanercept and ustekinumab', British Journal of Dermatology, vol. 185, no. 4, pp. 865-867. https://doi.org/10.1111/bjd.20527

TY - JOUR

T1 - Integrated safety analysis of treatment-emergent eczematous reactions in patients with moderate-to-severe psoriasis treated with ixekizumab, etanercept and ustekinumab

AU - Brunner, P. M.

AU - Conrad, C.

AU - Vender, R.

AU - Grond, S.

AU - Schuster, C.

AU - Patel, H.

AU - Xu, W.

AU - Carrascosa Carrillo, J. M.

N1 - Funding Information: sources: Eli Lilly and Company.we would like to thank Chenyun Tan, PharmD, an employee of Eli Lilly and Company, for medical writing assistance.

PY - 2021/10

Y1 - 2021/10

UR - https://www.scopus.com/pages/publications/85112037373

U2 - 10.1111/bjd.20527

DO - 10.1111/bjd.20527

M3 - Letter

C2 - 34076896

AN - SCOPUS:85112037373

SN - 0007-0963

VL - 185

SP - 865

EP - 867

JO - British Journal of Dermatology

JF - British Journal of Dermatology

IS - 4

ER -